| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 15 | 2025 | 563 | 1.350 |
Why?
|
| Proteome | 10 | 2024 | 274 | 1.040 |
Why?
|
| Protein Interaction Mapping | 6 | 2019 | 90 | 0.830 |
Why?
|
| Proteogenomics | 5 | 2025 | 107 | 0.720 |
Why?
|
| Estrogen Receptor alpha | 7 | 2023 | 419 | 0.710 |
Why?
|
| Breast Neoplasms | 11 | 2023 | 2586 | 0.670 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2025 | 267 | 0.670 |
Why?
|
| Immunoprecipitation | 6 | 2019 | 185 | 0.570 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 350 | 0.550 |
Why?
|
| Infertility, Male | 3 | 2024 | 285 | 0.500 |
Why?
|
| Algorithms | 6 | 2020 | 1635 | 0.490 |
Why?
|
| Peptides | 2 | 2020 | 826 | 0.470 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2025 | 555 | 0.450 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1750 | 0.430 |
Why?
|
| Multiprotein Complexes | 4 | 2013 | 193 | 0.420 |
Why?
|
| CRISPR-Cas Systems | 3 | 2024 | 277 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2015 | 312 | 0.380 |
Why?
|
| Mice | 25 | 2025 | 17578 | 0.380 |
Why?
|
| Mitosis | 2 | 2025 | 191 | 0.360 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 3465 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2025 | 930 | 0.360 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 1931 | 0.350 |
Why?
|
| Animals | 32 | 2025 | 33175 | 0.340 |
Why?
|
| Transcription Factors | 4 | 2025 | 2348 | 0.340 |
Why?
|
| HeLa Cells | 8 | 2019 | 689 | 0.330 |
Why?
|
| Proteins | 3 | 2023 | 1017 | 0.330 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 415 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2025 | 770 | 0.320 |
Why?
|
| Cysteine Endopeptidases | 1 | 2009 | 105 | 0.290 |
Why?
|
| DNA Helicases | 2 | 2024 | 229 | 0.290 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2025 | 1306 | 0.280 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 107 | 0.280 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2023 | 270 | 0.270 |
Why?
|
| Protein Phosphatase 2 | 2 | 2025 | 33 | 0.260 |
Why?
|
| Humans | 51 | 2025 | 125883 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2025 | 191 | 0.240 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 1 | 2025 | 4 | 0.240 |
Why?
|
| DNA | 4 | 2025 | 1430 | 0.240 |
Why?
|
| Receptors, Progesterone | 2 | 2025 | 664 | 0.240 |
Why?
|
| Axon Initial Segment | 1 | 2025 | 29 | 0.230 |
Why?
|
| Protein Binding | 8 | 2025 | 1673 | 0.230 |
Why?
|
| Fibrosis | 2 | 2024 | 393 | 0.230 |
Why?
|
| Estrogens | 4 | 2023 | 423 | 0.230 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2025 | 77 | 0.220 |
Why?
|
| Response Elements | 3 | 2013 | 101 | 0.220 |
Why?
|
| Acetylcysteine | 1 | 2025 | 79 | 0.210 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 23 | 0.210 |
Why?
|
| Proteolysis | 1 | 2025 | 177 | 0.210 |
Why?
|
| Gene Rearrangement | 1 | 2025 | 322 | 0.210 |
Why?
|
| Multigene Family | 1 | 2024 | 296 | 0.210 |
Why?
|
| Glycine | 1 | 2025 | 157 | 0.210 |
Why?
|
| Small Molecule Libraries | 1 | 2025 | 129 | 0.210 |
Why?
|
| Ribosomes | 2 | 2022 | 125 | 0.210 |
Why?
|
| Myeloproliferative Disorders | 1 | 2025 | 86 | 0.210 |
Why?
|
| Ubiquitination | 3 | 2025 | 164 | 0.210 |
Why?
|
| Glutathione | 1 | 2025 | 192 | 0.200 |
Why?
|
| Axons | 1 | 2025 | 372 | 0.190 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 132 | 0.190 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 62 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2023 | 560 | 0.190 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 10 | 0.190 |
Why?
|
| Esomeprazole | 1 | 2022 | 33 | 0.180 |
Why?
|
| Homocystinuria | 1 | 2022 | 26 | 0.180 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 2317 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 252 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 605 | 0.180 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 44 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2024 | 1211 | 0.180 |
Why?
|
| Female | 26 | 2025 | 67886 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2022 | 98 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2022 | 765 | 0.180 |
Why?
|
| Heart Atria | 1 | 2024 | 327 | 0.180 |
Why?
|
| Genetic Techniques | 1 | 2021 | 99 | 0.170 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1381 | 0.170 |
Why?
|
| Signal Transduction | 8 | 2025 | 4463 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 168 | 0.170 |
Why?
|
| Apoptosis | 3 | 2025 | 1801 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2025 | 509 | 0.170 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 62 | 0.170 |
Why?
|
| MCF-7 Cells | 5 | 2020 | 207 | 0.170 |
Why?
|
| Spliceosomes | 1 | 2021 | 47 | 0.170 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 110 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 586 | 0.170 |
Why?
|
| Testis | 1 | 2022 | 406 | 0.170 |
Why?
|
| Chromatin | 3 | 2015 | 488 | 0.170 |
Why?
|
| Carrier Proteins | 3 | 2023 | 1011 | 0.160 |
Why?
|
| Aging | 2 | 2025 | 1193 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 572 | 0.160 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 14 | 0.160 |
Why?
|
| Heart | 1 | 2025 | 645 | 0.160 |
Why?
|
| RNA, Messenger | 4 | 2019 | 2551 | 0.160 |
Why?
|
| HIV-1 | 2 | 2015 | 469 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 228 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 175 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 37 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2025 | 253 | 0.160 |
Why?
|
| Hormones | 1 | 2020 | 167 | 0.160 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 95 | 0.160 |
Why?
|
| Polyadenylation | 1 | 2020 | 46 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1570 | 0.160 |
Why?
|
| Mice, Knockout | 6 | 2024 | 3705 | 0.150 |
Why?
|
| Protein Biosynthesis | 2 | 2022 | 564 | 0.150 |
Why?
|
| Trastuzumab | 1 | 2020 | 143 | 0.150 |
Why?
|
| Claudins | 1 | 2018 | 30 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2024 | 2330 | 0.150 |
Why?
|
| Trophoblasts | 1 | 2019 | 113 | 0.150 |
Why?
|
| 3' Untranslated Regions | 1 | 2019 | 155 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 9 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 380 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 93 | 0.140 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 56 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 63 | 0.140 |
Why?
|
| Genetic Markers | 1 | 2019 | 599 | 0.140 |
Why?
|
| Intestines | 1 | 2022 | 581 | 0.140 |
Why?
|
| Genes | 1 | 2018 | 305 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 490 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 315 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 233 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2863 | 0.130 |
Why?
|
| Stem Cells | 1 | 2022 | 678 | 0.130 |
Why?
|
| Pars Compacta | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2018 | 564 | 0.130 |
Why?
|
| Trans-Activators | 4 | 2013 | 672 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 4503 | 0.130 |
Why?
|
| Drosophila | 1 | 2021 | 781 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 46 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 201 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 694 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 509 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2019 | 394 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 389 | 0.120 |
Why?
|
| Models, Biological | 3 | 2023 | 1374 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 16 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2025 | 1539 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 510 | 0.120 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 15 | 0.110 |
Why?
|
| Cell Movement | 1 | 2018 | 844 | 0.110 |
Why?
|
| Neurons | 2 | 2025 | 1908 | 0.110 |
Why?
|
| Karyopherins | 1 | 2015 | 35 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2025 | 658 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2025 | 232 | 0.110 |
Why?
|
| Male | 14 | 2025 | 62056 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 655 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 32 | 0.100 |
Why?
|
| Open Reading Frames | 2 | 2023 | 204 | 0.100 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cyclin T | 1 | 2012 | 31 | 0.100 |
Why?
|
| Endometriosis | 1 | 2015 | 169 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2012 | 33 | 0.100 |
Why?
|
| Semen | 2 | 2023 | 80 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 107 | 0.100 |
Why?
|
| Spermatogenesis | 2 | 2024 | 169 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2015 | 482 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2019 | 871 | 0.090 |
Why?
|
| Spermatozoa | 2 | 2024 | 238 | 0.090 |
Why?
|
| Software | 2 | 2013 | 711 | 0.090 |
Why?
|
| Chromatography, Liquid | 3 | 2023 | 228 | 0.090 |
Why?
|
| Fertility | 2 | 2024 | 250 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 685 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4423 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 722 | 0.090 |
Why?
|
| Glucose | 1 | 2015 | 845 | 0.090 |
Why?
|
| BRCA1 Protein | 1 | 2011 | 77 | 0.090 |
Why?
|
| Neoplasms | 2 | 2023 | 2833 | 0.090 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2025 | 80 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 348 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 2550 | 0.080 |
Why?
|
| Databases, Protein | 3 | 2020 | 59 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 20 | 0.080 |
Why?
|
| Oncogene Proteins | 2 | 2012 | 132 | 0.080 |
Why?
|
| Cell Line | 4 | 2019 | 2565 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3600 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 198 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 714 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 115 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2002 | 0.080 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2009 | 12 | 0.080 |
Why?
|
| Solubility | 1 | 2009 | 121 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 92 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2023 | 2393 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 102 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2009 | 208 | 0.070 |
Why?
|
| Liver | 2 | 2012 | 1752 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 833 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 725 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 3139 | 0.070 |
Why?
|
| Phenotype | 3 | 2023 | 4298 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2902 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2025 | 391 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 558 | 0.060 |
Why?
|
| Sex Factors | 2 | 2025 | 1292 | 0.060 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2025 | 14 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2006 | 71 | 0.060 |
Why?
|
| Ligands | 2 | 2020 | 478 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 103 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1879 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 128 | 0.060 |
Why?
|
| Transfection | 2 | 2019 | 949 | 0.060 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2024 | 9 | 0.060 |
Why?
|
| Quinolines | 1 | 2025 | 111 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 267 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1004 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2025 | 216 | 0.050 |
Why?
|
| Nitriles | 1 | 2025 | 141 | 0.050 |
Why?
|
| Imidazoles | 1 | 2025 | 212 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 339 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2024 | 103 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2025 | 403 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1721 | 0.050 |
Why?
|
| Mutation | 3 | 2023 | 5920 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 91 | 0.050 |
Why?
|
| Estradiol | 2 | 2020 | 475 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 636 | 0.050 |
Why?
|
| Purines | 1 | 2023 | 109 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2025 | 305 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 219 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2023 | 107 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 136 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 223 | 0.050 |
Why?
|
| Antioxidants | 1 | 2025 | 318 | 0.050 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2022 | 19 | 0.050 |
Why?
|
| Kidney | 1 | 2009 | 1261 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 351 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 34 | 0.050 |
Why?
|
| Sterols | 1 | 2022 | 16 | 0.050 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2023 | 49 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2025 | 313 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2022 | 18 | 0.050 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 23 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 18 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 714 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 56 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2024 | 767 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 73 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 131 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 329 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 92 | 0.040 |
Why?
|
| Cysteine | 1 | 2022 | 138 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 101 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 162 | 0.040 |
Why?
|
| Gentamicins | 1 | 2021 | 86 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 230 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2022 | 228 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2025 | 436 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 29 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2021 | 248 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 294 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 59 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 98 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 140 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 325 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2015 | 767 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 330 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 752 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 227 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 82 | 0.040 |
Why?
|
| Myocardium | 1 | 2025 | 835 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 250 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 412 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 99 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 283 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 34 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 287 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 443 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 245 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 231 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 305 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 622 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 273 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 111 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 547 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 25 | 0.040 |
Why?
|
| Computational Biology | 2 | 2015 | 839 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 132 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 567 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 131 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 67 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 34 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 65 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2018 | 53 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 350 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 189 | 0.040 |
Why?
|
| Diet | 1 | 2025 | 1099 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2019 | 286 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2018 | 68 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 651 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 372 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 415 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 974 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2017 | 87 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 705 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 541 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2017 | 48 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1779 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 134 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1064 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 3390 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 691 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 317 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 293 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1025 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 348 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 678 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1382 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 51 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 566 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1548 | 0.030 |
Why?
|
| Hippocampus | 1 | 2020 | 772 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 383 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 370 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 115 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 133 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1608 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 209 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 41 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 17 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 66 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2013 | 20 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 89 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 96 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 93 | 0.020 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2012 | 4 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2015 | 511 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2012 | 16 | 0.020 |
Why?
|
| Endometrium | 1 | 2015 | 265 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2012 | 17 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 409 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 122 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 51 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 602 | 0.020 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2012 | 59 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1009 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 113 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 169 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3018 | 0.020 |
Why?
|
| Ubiquitinated Proteins | 1 | 2010 | 3 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 364 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 129 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 298 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 192 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 1064 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2011 | 321 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 42 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 90 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1211 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6024 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 742 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 465 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 660 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 2772 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 495 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10351 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1019 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 473 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20022 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1193 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7392 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1489 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 6 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 9583 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 27322 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 224 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2005 | 179 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 351 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 829 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 1282 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 30246 | 0.010 |
Why?
|